MA47163A - Facteur 11 de différenciation de croissance activé protéolytiquement stabilisé - Google Patents

Facteur 11 de différenciation de croissance activé protéolytiquement stabilisé

Info

Publication number
MA47163A
MA47163A MA047163A MA47163A MA47163A MA 47163 A MA47163 A MA 47163A MA 047163 A MA047163 A MA 047163A MA 47163 A MA47163 A MA 47163A MA 47163 A MA47163 A MA 47163A
Authority
MA
Morocco
Prior art keywords
differentiation factor
growth differentiation
activated growth
stabilized activated
proteolytically
Prior art date
Application number
MA047163A
Other languages
English (en)
Inventor
Andreas Lehmann
R Blake Pepinsky
Dingyi Wen
Original Assignee
Biogen Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Ma Inc filed Critical Biogen Ma Inc
Publication of MA47163A publication Critical patent/MA47163A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA047163A 2016-12-16 2017-12-15 Facteur 11 de différenciation de croissance activé protéolytiquement stabilisé MA47163A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662435493P 2016-12-16 2016-12-16

Publications (1)

Publication Number Publication Date
MA47163A true MA47163A (fr) 2019-11-06

Family

ID=61007792

Family Applications (1)

Application Number Title Priority Date Filing Date
MA047163A MA47163A (fr) 2016-12-16 2017-12-15 Facteur 11 de différenciation de croissance activé protéolytiquement stabilisé

Country Status (4)

Country Link
US (2) US20200031895A1 (fr)
EP (1) EP3562840A1 (fr)
MA (1) MA47163A (fr)
WO (1) WO2018112362A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019144053A1 (fr) 2018-01-19 2019-07-25 President And Fellows Of Harward College Variants de gdf11 et leurs utilisations

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2053864C (fr) 1989-02-21 2001-11-20 Irving Boime Formes modifiees d'hormones de reproduction
EP0653942B2 (fr) * 1992-07-31 2007-03-07 Curis, Inc. Regeneration et reparation du systeme nerveux induites par morphogene
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
EP1803730A1 (fr) 2000-04-12 2007-07-04 Human Genome Sciences, Inc. Proteines de fusion d'albumine
WO2002076489A1 (fr) 2001-03-09 2002-10-03 Dyax Corp. Groupes de liaison d'albumine serique
US20080194481A1 (en) 2001-12-21 2008-08-14 Human Genome Sciences, Inc. Albumin Fusion Proteins
EP1997829A1 (fr) 2001-12-21 2008-12-03 Human Genome Sciences, Inc. Protéines de fusion d'albumine
KR101271635B1 (ko) 2001-12-21 2013-06-12 휴먼 게놈 사이언시즈, 인코포레이티드 알부민 융합 단백질
PL2460831T3 (pl) 2005-05-27 2017-05-31 Biogen Ma Inc. Przeciwciała wiążące tweak
EP1924596A4 (fr) 2005-08-12 2009-07-29 Human Genome Sciences Inc Protéines de fusion avec l'albumine
US8048848B2 (en) 2006-02-03 2011-11-01 Prolor Biotech Ltd. Long-acting interferons and derivatives thereof and methods thereof
GB0614780D0 (en) 2006-07-25 2006-09-06 Ucb Sa Biological products
KR20090064453A (ko) 2006-09-14 2009-06-18 휴먼 게놈 사이언시즈, 인코포레이티드 알부민 융합 단백질
CA2674140C (fr) 2007-01-05 2018-05-15 University Of Zurich Procede pour fournir des molecules de liaison et des cibles specifiques a une maladie.
PT2740744T (pt) 2007-01-09 2018-06-06 Biogen Ma Inc Anticorpos sp35 e suas utilizações
EP2508531B1 (fr) 2007-03-28 2016-10-19 President and Fellows of Harvard College Polypeptides piqués
US20080260738A1 (en) 2007-04-18 2008-10-23 Moore Margaret D Single chain fc, methods of making and methods of treatment
US20090252729A1 (en) 2007-05-14 2009-10-08 Farrington Graham K Single-chain Fc (scFc) regions, binding polypeptides comprising same, and methods related thereto
US8563521B2 (en) 2007-06-21 2013-10-22 Technische Universitat Munchen Biological active proteins having increased in vivo and/or in vitro stability
WO2010060112A1 (fr) 2008-11-24 2010-05-27 Aileron Therapeutics, Inc. Macrocycles peptidomimétiques avec propriétés améliorées
EP3124494B1 (fr) 2008-12-09 2019-06-19 Dana-Farber Cancer Institute, Inc. Procédés et compositions pour la modulation spécifique de mcl-1
KR101781228B1 (ko) 2008-12-19 2017-09-22 바이오겐 인터내셔널 뉴로사이언스 게엠베하 인간 항-알파-시누클레인 자가항체
JP2013502458A (ja) 2009-08-24 2013-01-24 アムニクス オペレーティング インコーポレイテッド 凝固第ｖｉｉ因子組成物ならびにそれを製造および使用する方法
SG189174A1 (en) 2010-10-11 2013-05-31 Biogen Idec Internat Neuroscience Gmbh Human anti-tau antibodies
MX357193B (es) 2011-06-23 2018-06-29 Univ Zuerich Moleculas de union anti-alfa sinucleina.
KR101961508B1 (ko) 2011-10-28 2019-03-25 바이오겐 인터내셔널 뉴로사이언스 게엠베하 Tdp-43 특이적 결합 분자
KR102234324B1 (ko) 2012-12-21 2021-03-31 바이오젠 엠에이 인코포레이티드 인간 항-타우 항체
ES2924479T3 (es) * 2013-04-08 2022-10-07 Harvard College Composiciones para rejuvenecer las células madre del músculo esquelético
PL3816625T3 (pl) * 2013-05-06 2026-01-26 Scholar Rock, Inc. Kompozycje i sposoby modulacji czynnika wzrostu
WO2016054005A1 (fr) * 2014-09-30 2016-04-07 The Medical College Of Wisconsin, Inc. Plate-forme universelle pour des thérapies de ciblage pour traiter des maladies neurologiques
MA40835A (fr) 2014-10-23 2017-08-29 Biogen Ma Inc Anticorps anti-gpiib/iiia et leurs utilisations
EP3324996A4 (fr) * 2015-07-22 2019-04-17 Scholar Rock, Inc. Protéines de liaison à gdf11 et leurs utilisations

Also Published As

Publication number Publication date
EP3562840A1 (fr) 2019-11-06
WO2018112362A1 (fr) 2018-06-21
US20220348623A1 (en) 2022-11-03
US20200031895A1 (en) 2020-01-30

Similar Documents

Publication Publication Date Title
IL266306A (en) Control of agricultural production areas
EP3522831C0 (fr) Implant de néo-phallus
DK3393512T3 (da) Rsv f-proteinmutanter
GB2548695B (en) Horticultural lighting device
PL3532768T3 (pl) Oświetlenie terenu
DK3027642T3 (da) Vækstdifferentieringsfaktor 15 (gdf-15)-konstruktioner
IL252161B (en) Stabilized omega-3 ophthalmic compositions
EP3499163A4 (fr) Four de frittage
EP3402423C0 (fr) Dispositif d'implant
EP3405581A4 (fr) Protéines antimicrobiennes
PT3389357T (pt) Sistema para a iluminação de grandes relvados
PL3653377T3 (pl) Materiał dekoracyjny
EP3425648A4 (fr) Solénoïde
PT3644728T (pt) Congelamento de material biológico
LT3242547T (lt) Apšvietimas sodininkystės ir kitoms reikmėms
EP3332319A4 (fr) Filtrage de commandes d'écriture
IT201700117210A1 (it) Fungicida biologico
BR112016019708A2 (pt) compostos reguladores do crescimento de plantas
BR112017025415A2 (pt) compostos reguladores do crescimento de plantas
EP3467158A4 (fr) Creuset
GB201617548D0 (en) Novel biological factor
MA47163A (fr) Facteur 11 de différenciation de croissance activé protéolytiquement stabilisé
EP3556325A4 (fr) Implant
EP3441991A4 (fr) Solénoïde
EP3168671C0 (fr) Arrangement d'illumination